FDA — authorised 25 February 2015
- Application: BLA206538
- Marketing authorisation holder: SANOFI US SERVICES
- Local brand name: TOUJEO SOLOSTAR
- Indication: SOLUTION — SUBCUTANEOUS
- Status: approved
🇺🇸 Toujeo SoloStar in United States
FDA authorised Toujeo SoloStar on 25 February 2015
Marketing authorisation
Other Diabetes approved in United States
Frequently asked questions
Is Toujeo SoloStar approved in United States?
Yes. FDA authorised it on 25 February 2015.
Who is the marketing authorisation holder for Toujeo SoloStar in United States?
SANOFI US SERVICES holds the US marketing authorisation.